Health Universe
Category: AI in Healthcare
An enterprise AI infrastructure platform designed to deploy, share, and monetize clinical AI applications and agentic workflows within regulated healthcare environments. Health Universe was founded in 2023. The company is led by Dan Caron. Based in San Francisco, USA. Team size: 11-50. Total funding raised: $9.5M. Latest round: Seed. Key investors include Kleiner Perkins, Susa Ventures, Twelve Below, Oncology Ventures.
- Founded
- 2023
- Headquarters
- San Francisco, USA
- Team size
- 11-50
- Total funding
- $9.5M
Value proposition
Dramatically reduces the 'bench-to-bedside' gap for clinical AI by providing a validated, interoperable 'agentic layer' that allows health systems to deploy AI agents in days rather than months.
Products and solutions
Agentic Workflow Orchestrator (A2A Orchestration), Health AI Marketplace (Model sharing and monetization), Clinical Deployment Infrastructure (Interoperable API layer), Validated AI Agent Library (Pre-vetted clinical and administrative agents), Open-Source Clinical Deployment Toolkit
Unique value
Focuses on 'Agent-to-Agent' (A2A) orchestration specifically for medicine, creating a collaborative ecosystem where different AI models can interact to solve complex clinical workflows.
Target customer
Health systems, academic medical centers, clinical AI developers, and enterprise healthcare organizations.
Industries served
Healthcare, Health Information Technology, Clinical Research, Academic Medicine
Technology advantage
Combines deep clinical informatics expertise with a low-code infrastructure that bypasses traditional IT bottlenecks, enabling rapid integration of academic AI research into real-world clinical settings.
How they differentiate
Focuses on 'Agent-to-Agent' (A2A) orchestration and a low-code infrastructure layer that allows health systems to deploy validated AI agents in days, bypassing traditional IT and interoperability bottlenecks.
Main competitors
Hippocratic AI, Aidoc, Dandelion Health
Key partnerships
Kleiner Perkins (Lead Investor), Susa Ventures, Twelve Below, Oncology Ventures, Kno2 (QHIN / TEFCA record retrieval), Atropos Health (real-world evidence / clinical decision support), American Medical Informatics Association (AMIA) - via leadership ties
Notable customers
Duke Clinical Research Institute (DCRI), New York Cancer and Blood Specialists, Emory University, Academic Medical Centers, Enterprise Health Systems
Major milestones
Founded in 2023 by Dan Caron (former founder of Arrive Health), Developed the 'Agentic Layer' for healthcare clinical workflows, Secured $6M Seed funding led by Kleiner Perkins in March 2026, Partnered with Kno2 (QHIN) for TEFCA nationwide record retrieval (Dec 2025), Partnered with Atropos Health to embed real-world evidence into clinical AI workflows (Aug 2026), Established a marketplace for the monetization of academic AI research
Growth metrics
Early growth stage; transitioned from stealth to active enterprise deployment with a team size of 11-50 employees.
Market positioning
Enterprise AI infrastructure and marketplace provider (the 'plumbing' for clinical AI deployment).
Geographic focus
North America
Patents and IP
No specific registered patents disclosed; proprietary advantage lies in orchestration logic and clinical data interoperability frameworks.
About Dan Caron
Dan Caron is a seasoned health-tech entrepreneur and innovator. He previously founded Arrive Health (formerly RxRevu), which raised over $32M to improve prescription transparency. He gained significant recognition for 'hacking' an insulin pump to create an automated pancreas system that eventually received FDA approval. He is a specialist in health AI, interoperability, and open-source clinical deployment.
Latest news about Health Universe
More AI in Healthcare companies
Official website: https://www.healthuniverse.com